BARBANTI, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 2.724
AS - Asia 2.007
EU - Europa 495
Continente sconosciuto - Info sul continente non disponibili 67
SA - Sud America 27
AF - Africa 26
OC - Oceania 10
Totale 5.356
Nazione #
US - Stati Uniti d'America 2.291
TR - Turchia 1.046
SG - Singapore 430
CA - Canada 429
CN - Cina 413
IT - Italia 157
IE - Irlanda 71
EU - Europa 65
UA - Ucraina 63
IN - India 48
RU - Federazione Russa 45
DE - Germania 35
HK - Hong Kong 30
FI - Finlandia 27
GB - Regno Unito 26
BR - Brasile 22
NL - Olanda 17
SC - Seychelles 16
ES - Italia 10
FR - Francia 8
SE - Svezia 8
AU - Australia 7
EG - Egitto 6
IL - Israele 6
JP - Giappone 6
IR - Iran 5
PK - Pakistan 5
CL - Cile 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
MX - Messico 4
RO - Romania 4
TW - Taiwan 4
NO - Norvegia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
HR - Croazia 2
ID - Indonesia 2
KR - Corea 2
MN - Mongolia 2
MT - Malta 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
KZ - Kazakistan 1
LB - Libano 1
PL - Polonia 1
TH - Thailandia 1
Totale 5.356
Città #
Kocaeli 926
San Mateo 664
Toronto 419
Wilmington 223
Houston 178
Santa Clara 177
Lawrence 140
Princeton 140
Singapore 136
Beijing 102
Ashburn 84
Fairfield 74
Seattle 51
Chandler 49
West Jordan 46
Redwood City 43
Shanghai 38
Los Angeles 35
Woodbridge 34
Rome 29
Hong Kong 28
Guangzhou 26
Cambridge 24
Dublin 24
Helsinki 24
Milan 15
Brooklyn 13
Shenzhen 13
Vicenza 13
Saint Petersburg 8
Andover 7
Rui'an 7
Suffern 7
Wuhan 7
St Petersburg 6
Wuxi 6
Ann Arbor 5
Borås 5
Jiaxing 5
London 5
Munich 5
Pune 5
Quanzhou 5
Washington 5
Xi'an 5
Fontebuona 4
Nanjing 4
Nantong 4
Philadelphia 4
Redmond 4
Sanming 4
Carol Stream 3
Dongyang 3
Florence 3
Gatchina 3
Kiev 3
Kyiv 3
Lisbon 3
Malo 3
Mexico City 3
Moscow 3
Murfreesboro 3
New York 3
Perm 3
Rio De Janeiro 3
Rockville 3
São Paulo 3
Taizhou 3
Algiers 2
Ancona 2
Arce 2
Assago 2
Auckland 2
Central District 2
Chengdu 2
Comun Nuovo 2
Drakulica Rijeka 2
Erie 2
Fort Huachuca 2
Foshan 2
Haining 2
Jining 2
Karachi 2
Katsumi 2
Knoxville 2
Krimpen Aan Den Ijssel 2
Kumar 2
Las Pinas 2
Latina 2
Litvinov 2
Madinat an Nasr 2
Madrid 2
Marcianise 2
Melita 2
Norwalk 2
Ottawa 2
Parma 2
Phoenix 2
Piqua 2
Rubano 2
Totale 4.000
Nome #
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 116
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 92
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 85
A case - control study on excessive daytime sleepiness in episodic migraine 71
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 70
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 69
A case-control study on excessive daytime sleepiness in chronic migraine 69
A case-control study on excessive daytime sleepiness in chronic migraine 65
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 57
Unilateral cranial autonomic symptoms in migraine 53
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 51
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 49
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 49
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 48
Acupuncture in cluster headache: Four cases and review of the literature 48
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 47
Late motor recovery is influenced by muscle tone changes after stroke 47
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 46
Dopamine hypersensitivity in migraine: Role of the apomorphine test 46
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 46
Ketogenic diet in migraine: rationale, findings and perspectives 45
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 45
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 45
Dopamine and migraine: Does Parkinson's disease modify migraine course? 45
Treatment of tension-type headache: from old myths to modern concepts 45
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 45
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 45
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 44
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 44
Acute pathological laughter induced by sumatriptan 44
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 44
Machine learning approach to predict medication overuse in migraine patients 44
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 43
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 43
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 43
Migraine and movement disorders 43
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 43
Tardive dyskinesias in the elderly 43
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 43
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 42
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 42
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 42
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 42
Real-world insights on the management of migraine patients: an Italian nationwide study 42
A mechanism-based classification of pain in multiple sclerosis 41
Donepezil in the treatment of progressive supranuclear palsy 41
Cluster headache: management of acute attacks before triptans 41
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 41
Shortened cortical silent period in facial muscles of patients with migraine 40
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 40
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 40
Tension type headache: a neuropsychological and neurophysiological study 40
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 40
Use of dopamine agonists in aged patients with Parkinson's disease 39
Drugs targeting nitric oxide synthase for migraine treatment 39
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 39
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 39
Migraine attack delays gastric emptying: an ultrasonographic study 38
Trigeminal sensory pathway function in patients with SUNCT 38
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 38
Impairment of trigeminal sensory pathways in cluster headache 38
Migraine and the extrapyramidal system 38
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 37
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 37
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 37
Hypertension as a risk factor for migraine chronification 37
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 37
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 36
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 36
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 36
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 36
A proposal for a national registry on chronic migraines 36
Restless legs syndrome is not associated with migraine with aura: a clinical study 36
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 36
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 36
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 35
Excessive daytime sleepiness in untreated Parkinson's disease patients: Follow-up after 1 year of dopaminergic drug therapy 35
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 34
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 34
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies 34
Migraine prophylaxis: what is new and what we need? 34
The role of dopamine in migraine 34
Redox mechanisms in migraine: novel therapeutics and dietary interventions 33
CEP Cortelli Corrigendum for 515342 (vol 34, pg 434, 2014) 33
Symptomatic cluster headache following an ischaemic lesion of the trigemino-cervical complex 33
Rational for using SSRI (selective serotonin uptake inhibitors) in migraine prophylaxis 33
Unilateral Cranial Autonomic Symptoms in Migraine: A Retrospective Case Series on 757 Patients 33
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 33
Pharmacotherapy for acute migraines in children and adolescents 33
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 32
No association between essential tremor and migraine: A case-control study 32
Socio-economic costs of migraine 32
The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients 32
Increased thrombophilic predisposition in premenopausal females with chronic migraine 32
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 31
Migraine and Tourette syndrome 31
Future trends in drugs for migraine prophylaxis 31
Headache in chronic cocaine users: A cross-sectional study 31
Pharmacological Trials in Migraine: It's Time to Reappraise Where the Headache Is and What the Pain Is Like 31
Headache in cranial and cervical dystonia 30
Totale 4.269
Categoria #
all - tutte 60.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020198 0 0 0 0 0 0 0 0 0 0 79 119
2020/20211.526 78 64 26 16 49 78 58 35 47 73 940 62
2021/20221.377 18 419 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.242 81 221 128 52 86 257 111 107 176 22 1 0
Totale 5.583